A de novo Alu insertion results in neurofibromatosis type 1
- 1 October 1991
- journal article
- case report
- Published by Springer Nature in Nature
- Vol. 353 (6347) , 864-866
- https://doi.org/10.1038/353864a0
Abstract
NEUROFIBROMATOSIS type 1 (NF1) is a common autosomal dominant disorder with a high mutation rate and variable expression, characterized by neurofibromas, café-au-lait spots, Lisch nodules of the iris, and less frequent features including bone deformities and learning disabilities1. The recently cloned NF1 gene encodes a transcript of 13 kilobases from a ubiquitously expressed locus on chromosome 17 (refs. 2–4). Most NF1 patients are expected to have unique mutations, but only a few have so far been characterized, restricting genetic and functional information and the design of DNA diagnostics. We report an unusual NF1 mutation, that of a de novo Alu repetitive element insertion into an intron, which results in deletion of the downstream exon during splicing and consequently shifts the reading frame. This previously undescribed mechanism of mutation indicates that Alu retrotrans-position is an ongoing process in the human germ line.Keywords
This publication has 16 references indexed in Scilit:
- A human-specific subfamily of Alu sequencesGenomics, 1991
- Reconstruction and analysis of human alu genesJournal of Molecular Evolution, 1991
- Identical 3250-bp deletion between two AluI repeats in the ADA genes of unrelated ADA−SCID patientsGenomics, 1990
- Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 PatientsScience, 1990
- A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutationsPublished by Elsevier ,1990
- Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locusCell, 1990
- Paternal origin of new mutations in Von Recklinghausen neurofibromatosisNature, 1990
- Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.Proceedings of the National Academy of Sciences, 1989
- Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements.Journal of Clinical Investigation, 1988
- Duplication of seven exons in LDL receptor gene caused by Alu-Alu recombination in a subject with familial hypercholesterolemiaCell, 1987